Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC013694 | Panoply™ Human RUNX2 Knockdown Stable Cell Line | Inquiry |
| CSC-SC013694 | Panoply™ Human RUNX2 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1786 | RUNX2 Knockout Cell Line-HeLa | Inquiry |
| CLKO-1635 | RUNX2 KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD00249Z | Human RUNX2 adenoviral particles | Inquiry |
| AD14139Z | Human RUNX2 adenoviral particles | Inquiry |
| LV24549L | human RUNX2 (NM_004348) lentivirus particles | Inquiry |
| LV24550L | human RUNX2 (NM_001024630) lentivirus particles | Inquiry |
| LV24551L | human RUNX2 (NM_001015051) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH400788 | shRNA set against Mouse RUNX2 (NM_009820.5) | Inquiry |
| SHH400784 | shRNA set against Human RUNX2 (NM_004348.3) | Inquiry |
| SHH400792 | shRNA set against Rat RUNX2 (NM_053470.2) | Inquiry |
| SHW004647 | shRNA set against Chicken RUNX2 (NM_204128) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCH399382 | Mouse RUNX2 ORF clone(NM_009820.5) | Inquiry |
| CDCH399383 | Rat RUNX2 ORF clone(NM_053470.2) | Inquiry |
| CDFH016798 | Human RUNX2 cDNA Clone(NM_004348.3) | Inquiry |
| MiUTR1H-09081 | RUNX2 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-07142 | RUNX2 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-03189 | RUNX2 miRNA 3'UTR clone | Inquiry |
| CDCB166122 | Chicken RUNX2 ORF Clone (NM_204128) | Inquiry |
| CDCB195559 | Rabbit RUNX2 ORF clone (XM_008262992.1) | Inquiry |
| CDCH076396 | human RUNX2 ORF clone (NM_001024630.3) | Inquiry |
| CDCH076398 | human RUNX2 ORF clone (NM_001015051.3) | Inquiry |
| CDCH399380 | Mouse RUNX2 ORF clone(NM_001145920.2) | Inquiry |
| CDCR238262 | Mouse Runx2 ORF Clone(NM_001146038.2) | Inquiry |
| CDCR287839 | Human RUNX2 ORF Clone(NM_004348.3) | Inquiry |